 
| Course: |
Autoantibodies to Factor VIII: Diagnosis and Management of Acquired Hemophilia
A Free CME/CE Certified Webcast-on-Demand |
| Target Audience: |
This activity has been designed to meet the educational needs of hematologists, pediatric hematologists, hematologists/oncologists, emergency medicine providers, fellows, hospitalists, nurses, and other health care professionals involved in the treatment of patients with acquired hemophilia.
Course Description:
This educational activity will provide the clinician with a better understanding of the etiology and pathophysiology of the development of factor VIII inhibitors, the
tools to accurately diagnose acquired hemophilia (AH), and the knowledge to apply treatment protocols to improve the outcome of patients with AH. |
| Sponsor: |
This activity is co-provided by SCEPTER™, EduPro Resources LLC, and Quintiles Medical Education.
Grantor
This activity is supported by an educational grant from Novo Nordisk.
|
| Accreditation: |
SCEPTER is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.
Estimated time to complete this activity: 1 hour.
Content Review
This activity has been reviewed for relevance, accuracy of content, and fair balance by CME Peer Review, LLC.
|
| Credit Designation: |
| SCEPTER designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. |
| Faculty Listing: |
Louis M. Aledort, MD
The Mary Weinfeld Professor of
Clinical Research in Hemophilia
Mount Sinai School of Medicine
New York, New York
Catherine S. Manno, MD
Pat and E. John Rosenwald Professor and Chair
Department of Pediatrics
NYU Langone Medical Center
New York University
New York, New York |
| Subjects: |
- Autoantibodies to Factor VIII: Diagnosis and Management of Acquired Hemophilia
|
| Objectives: |
- Integrate diagnostic knowledge to rapidly differentiate between acquired hemophilia and other bleeding disorders
- Institute appropriate treatment options in the acute setting to decrease the morbidity and mortality associated with acquired hemophilia
- Apply published clinical data to the care and management of patients with acquired hemophilia
|
| Financial Disclosure: |
David Nederhood, PharmD, has no significant financial relationships to disclose.
Co-Chairpersons Disclosures:
Louis M. Aledort, MD, has served on the speakers bureaus for Amgen and GlaxoSmithKline. He has also received an educational grant from Novo Nordisk. He has acted as a consultant and developed educational material for Baxter and Grifols.
Catherine S. Manno, MD, has served as a consultant for Bayer Healthcare.
Policy on Disclosure:
SCEPTER and Quintiles Medical Education adhere to the ACCME Essential Areas and Policies, including the Standards for Commercial Support, regarding industry support of CME. Disclosure information is provided during the planning process to ensure resolution of any identified conflicts. Disclosure of faculty and commercial relationships, as well as the discussion of unlabeled or unapproved use of any drug, device, or procedure by the faculty, will be disclosed to learners.
CME Peer Review, LLC, Conflict of Interest Resolution Statement:
Reviewers are required to disclose all relevant relationships with any commercial interest to CME Peer Review, LLC, prior to being accepted as a reviewer. Reviewers are required to update such information, are vetted and are determined to be free of conflict of interest prior to conducting each activity content evaluation.
Disclaimer:
The opinions expressed herein are those of the authors and do not necessarily represent the views of SCEPTER, EduPro Resources, and Quintiles Medical Education. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings, and adverse effects before administering pharmacologic therapy to patients.
|
- You are not currently logged in.
- To view content articles and complete the post-test for this course, please login or register now
|
|
